Document is current
Any future updates will be listed below
-
Authors
Sahin, U. https://orcid.org/0000-0003-0363-1564
Schmidt, M. https://orcid.org/0000-0003-1365-2414
Derhovanessian, E.
Cortini, A.
Vogler, I. https://orcid.org/0000-0001-9757-9618
Omokoko, T.
Godehardt, E.
Attig, S.
Newrzela, S.
Grützner, J.
Bidmon, N.
Bolte, S.
Brachtendorf, S.
Stuhlmann, T.
Langer, D.
Brüne, D.
Blake, J.
Feldner, A.
Lindman, H. https://orcid.org/0000-0002-5871-268X
Schneeweiss, A.
Eichbaum, M.
Türeci, Ö.
- License Information
-
More Information
Article History
Received: 6 November 2024
Accepted: 3 December 2025
First Online: 18 February 2026
Competing interests
: U.S. and Ö.T. are management board members and employees at BioNTech SE. E.D., A.C., I.V., T.O., E.G., S.N., J.G., N.B., S. Bolte, S. Brachtendorf, J.S., T.S., D.L., D.B., J.B. and A.F. are employees at BioNTech SE. U.S. and Ö.T. are inventors on patents and patent applications related to RNA technology. U.S., E.D., A.C., I.V., T.O., E.G., S.N., J.G., N.B., S. Bolte, S. Brachtendorf, J.S., T.S., D.L., D.B., J.B., A.F. and Ö.T. have equity interests in BioNTech SE. M.S. reports personal fees from AstraZeneca, BioNTech, Daiichi Sankyo, Eisai, Exact Sciences, Gilead, Lilly, Menarini-Stemline, Molecular Health, MSD, Novartis, Pantarhei Bioscience, Pfizer, Pierre Fabre, Roche and SeaGen, His institution has received research funding from AstraZeneca, BioNTech, Eisai, Genentech, German Breast Group, Novartis, Palleos, Pantarhei Bioscience, Pierre Fabre and SeaGen. In addition, M.S. is an inventor on patents EP 2390370 B1 and EP 2951317 B1.
